AcuityMD, an AI-powered medtech intelligence platform, has been named to Forbes’ 2025 'Next Billion-Dollar Startups' list, recognizing it as one of 25 U.S.-based venture-backed startups most likely to reach a $1 billion valuation. The company, founded in 2019, has grown rapidly, signing 300 customers, launching two new products, and doubling its staff. It raised $45 million in a Series B funding round in 2024, bringing its total funding to over $83 million. AcuityMD is trusted by leading MedTech companies such as Becton Dickinson, Teleflex, and Olympus, and was recently named to Newsweek’s 'America’s Greatest Startup Workplaces 2025.' The Forbes list evaluates startups based on valuation, revenue, customer count, and employee headcount, with a strong track record of identifying future unicorns.

Becton, Dickinson and Company (BD) has launched a new at-home HPV testing solution that allows women to self-collect a sample using a simple, Q-tip-sized swab. The test, known as the BD Onclarity Assay, enables convenient, private, and non-invasive screening without requiring a pelvic exam or clinic visit. The sample can be mailed directly to a lab, where it is automatically processed using the BD COR System, eliminating the need for manual handling. The test can identify multiple high-risk HPV strains, surpassing current alternatives. The product aligns with recommendations from the American Society for Colposcopy and Cervical Pathology (ASCCP) and is under consideration by the U.S. Preventive Services Task Force (USPSTF). A 2024 Harris Poll survey found that 72% of U.S. women delayed gynecology visits, and 81% expressed a preference for less invasive, at-home testing options.

The global sustainable pharmaceutical packaging market is projected to reach over USD 372.46 billion by 2034, growing at a CAGR of 15.2%. Industry players are investing in research and development to create environmentally responsible packaging using recycled materials, biodegradable alternatives, and recyclable solutions. Demand from consumers and healthcare professionals is increasing for sustainable, functional packaging. Growth is driven by technological advancements, rising healthcare access, and the expansion of generic medications, particularly in emerging markets like China, India, and Brazil. North America leads the market due to strong sustainability initiatives, while the Asia-Pacific region is expanding rapidly due to population size, healthcare spending, and supportive regulations. Key players include Berry Global Inc., Gerresheimer AG, Amcor Plc., Schott AG, Aptargroup, Inc., Becton Dickinson and Company, Westrock Company, Nipro Corporation, Catalent, Inc., Sealed Air Corporation, and West Pharmaceutical Services, Inc. A notable development is WestRock Company's 2022 collaboration with Recipe Unlimited to develop recyclable paperboard products that will prevent 31 million plastic containers from entering Canadian landfills annually.

The global sustainable pharmaceutical packaging market is projected to reach over USD 372.46 billion by 2034, growing at a CAGR of 15.2%. Industry players are investing in research and development to create packaging that is recyclable, uses recycled materials, and reduces environmental impact. Demand from consumers and healthcare professionals is rising for sustainable, functional packaging. Key drivers include environmental concerns, consumer preference for recycled and biodegradable materials, and expansion in healthcare access. Challenges include volatile raw material prices and higher manufacturing costs. North America leads the market, supported by strong sustainability initiatives, while the Asia-Pacific region is expanding rapidly due to population size, healthcare growth, and government support. Recent developments include a collaboration between WestRock Company and Recipe Unlimited to develop recyclable paperboard products that will prevent 31 million plastic containers from ending up in Canadian landfills.

A market research report by Custom Market Insights analyzes the US surgical instrument tracking market, estimating its size at USD 74.48 million in 2024, USD 83.25 million in 2025, and reaching USD 226.61 million by 2034 at a CAGR of 11.78%. The growth is driven by rising surgical volumes, chronic diseases, and patient safety concerns, with key market players including Vizinex (HID Global Corporation), Fortive, Becton Dickinson (BD), Steris, Integra LifeSciences, Censis, Surlogs, Stryker, Medtronic, B. Braun SE, Olympus Corporation, Case Medical, Scanlan International, Inc., and Securitas Healthcare LLC. The market is segmented by technology (barcodes, RFID), application (hardware, software, services), and end-use (hospitals, ambulatory surgical centers). Key trends include the adoption of RFID and AI-driven analytics, regulatory compliance with UDI standards, and challenges related to data security and integration with existing hospital systems.